AU4598400A - Method of treatment - Google Patents

Method of treatment

Info

Publication number
AU4598400A
AU4598400A AU45984/00A AU4598400A AU4598400A AU 4598400 A AU4598400 A AU 4598400A AU 45984/00 A AU45984/00 A AU 45984/00A AU 4598400 A AU4598400 A AU 4598400A AU 4598400 A AU4598400 A AU 4598400A
Authority
AU
Australia
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45984/00A
Other languages
English (en)
Inventor
Andrew Martin Jones
Michael J. Reinstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9911499.3A external-priority patent/GB9911499D0/en
Priority claimed from GB0002762A external-priority patent/GB0002762D0/en
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU4598400A publication Critical patent/AU4598400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AU45984/00A 1999-05-19 2000-05-16 Method of treatment Abandoned AU4598400A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9911499.3A GB9911499D0 (en) 1999-05-19 1999-05-19 Medicament
GB9911499 1999-05-19
GB0002762 2000-02-08
GB0002762A GB0002762D0 (en) 2000-02-08 2000-02-08 Method of treatment
PCT/GB2000/001875 WO2000071106A2 (fr) 1999-05-19 2000-05-16 Methode de traitement

Publications (1)

Publication Number Publication Date
AU4598400A true AU4598400A (en) 2000-12-12

Family

ID=26243587

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45984/00A Abandoned AU4598400A (en) 1999-05-19 2000-05-16 Method of treatment

Country Status (6)

Country Link
EP (1) EP1223939A1 (fr)
JP (1) JP2003500353A (fr)
AU (1) AU4598400A (fr)
CA (1) CA2363784A1 (fr)
HK (1) HK1048440A1 (fr)
WO (1) WO2000071106A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1795199A3 (fr) * 2001-02-06 2007-07-25 AstraZeneca AB Quétiapine pour traiter la dépendance à une substance ou l'abus d'une substance
DE60219761T2 (de) 2001-02-06 2008-01-17 Astrazeneca Ab Verwendung von quetiapin für die behandlung von kokain-abhängigkeit
NZ530724A (en) * 2001-07-23 2005-09-30 Corcept Therapeutics Inc Methods for preventing antipsychotic-induced weight gain
CA2553309A1 (fr) * 2004-04-22 2005-11-03 Mor Research Applications Ltd. Methode de gestion de la prise d'aliments

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9604465D0 (en) * 1996-03-01 1996-05-01 Smithkline Beecham Plc Novel method
GB9615767D0 (en) * 1996-07-26 1996-09-04 Smithkline Beecham Plc Novel treatment
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses
CA2366838A1 (fr) * 1999-03-18 2000-09-21 Gina Guadagno Traitement de la boulimie et de troubles de l'alimentation associes par administration d'antipsychotiques atypiques

Also Published As

Publication number Publication date
WO2000071106A3 (fr) 2002-05-10
CA2363784A1 (fr) 2000-11-30
JP2003500353A (ja) 2003-01-07
WO2000071106A2 (fr) 2000-11-30
EP1223939A1 (fr) 2002-07-24
HK1048440A1 (zh) 2003-04-04

Similar Documents

Publication Publication Date Title
GB2351661B (en) Novel method of treatment
AU2001249881A1 (en) Method of treating the heart
IL145875A0 (en) Novel method of treatment
AU2001286983A1 (en) Method of treatment
AU7750100A (en) Method for the treatment of obesity
AU2001262177A1 (en) Method of treatment
AU4598400A (en) Method of treatment
GB9930688D0 (en) Novel method of treatment
AU2382601A (en) Novel method of treatment
AU2001253560A1 (en) Methods of treatment
AU1108101A (en) Method of treating plants
AU8038400A (en) Method of treatment of influenza
AUPQ320299A0 (en) Method of treatment
AUPQ233299A0 (en) Method of treatment
AUPQ080999A0 (en) Method of treatment
AU1784701A (en) Method of treating neuroblastoma
GB9930696D0 (en) Novel method of treatment
AUPP460798A0 (en) Method of treatment
AUPP193198A0 (en) Method of treatment
AUPP795298A0 (en) Method of treatment
AUPP225098A0 (en) Method of treatment
AUPP363398A0 (en) Method of treatment
AUPP584798A0 (en) Method of treatment
AUPR213000A0 (en) Method of treatment
AUPQ662500A0 (en) Method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase